Publications | LMC Healthcare: Helping You Understand and Control your Diabetes

RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia

研究热点：格列美脲/利克塞那肽固定比例胰岛素组合可改善血糖变异性和血糖控制，同时不会增加低血糖症状

由 LMC Healthcare | 2 月 28, 2019 | News, Publications

LMC Manna Research的首席医疗官罗尼-阿伦森（Ronnie Aronson）博士分享了我们的最新出版物，该出版物展示了我们在过去十年中与利血那肽和利喜兰（利血那肽和兰图斯复方制剂）这两种药物开展的合作。该出版物是我们与利血那肽和利喜兰（利血那肽和兰图斯复方制剂）合作的成果。

LMC 技能、信心和准备指数（SCPI）：开发和评估用于评估糖尿病患者自我管理情况的新型工具

由 LMC Healthcare | 2 月 3, 2017 | Publications

2017年初，LMC糖尿病与内分泌科在《健康与生活质量结果》杂志上发表了一篇关于我们的新工具--LMC技能、信心与准备指数（SCPI）的论文。SCPI是一种新工具，可用于评估...

The Elixa and Tecos trial results are in!

Elixa 和 Tecos 的试验结果出来了！

由 LMC Healthcare | 4 月 8, 2014 | Publications

One of our very own Dr. Goldenberg reviews the results from the report for the #ELIXA and #TECOS trials – they were a focal point of interest at American Diabetes Association‘s #ADA75 this year in Boston. See more footage of him responding to some key questions...